Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Randox Laboratories' KRAS/BRAF/PIK3CA Array


Randox Laboratories this week launched its KRAS/BRAF/PIK3CA Array. The company said that clinicians can use the chip to select appropriate patients for colorectal cancer patients undergoing anti-EGFR therapy.

The KRAS/BRAF/PIK3CA Array is designed for the qualitative detection of point mutations within the genes KRAS, BRAF and PIK3CA from tissue DNA, Randox said.

The array is compatible for use with a range of genomic DNA samples including; cell lines, formalin-fixed, paraffin-embedded tissue and fresh/frozen tissue.